4:45 PM - 5:00 PM (PDT), Monday, June 13, 2022
Photolitec is a Biotech company in drug discovery and early drug development phase that focuses on new imaging agents and PhotoDynamic Therapy (PDT) and SonoDynamic Therapy (SDT). We are spinoff of the Roswell Park cancer Institute.

Mode of action
1) New Photosensitizers only for fluorescence imaging, Localization of tumor and cancer cells
Florescence guided surgery.

2) Photosensitizers for Imaging, Diagnose and cancer Treatment
Activation of Photosensitizers with
Photodynamic therapy-PDT (light of laser- penetration) or Sonodynamic therapy SDT (sound penetration- no limitation)
3) Compounds
-PET-ONCO is a radiopharmaceutical (i124) or a Radioactive version for fluorescence guided surgery
-PHOTOBAC: deepest penetration (up to 800 nm/Infrared)
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3 to 4
Chief Operating Officer